News from the past week on GUV.
Catch up with all you might have missed with our regular roundup:
Graph points towards $18.5m for Dato
Carnegie Mellon University spin-out Dato, formerly GraphLab, raises $18.5m.
MINTS breathing fresh air into Michigan startups
Michigan’s $25m MINTS venture fund records 11 investments totalling $6.9m.
Nottingham feels the beat for tiny feet
Nottingham University partners Tioga to develop heartrate monitoring technology for babies.
Nutrition firm Olygose raises €5m with backing from Catholic University of Louvain.
Colorado spins out EnteroTrack to develop gastrointestinal tract device.
Profector adapts to collaboration
Maynooth University spin-out Profector Life Sciences enters into collaboration deal with Adapt Pharma.
Moderna trumps all other biotech rounds
Moderna Therapeutics, a US-based life sciences firm with ties to multiple universities, closes biggest biotech venture capital round in history at $450m.
Juno Therapeutics completes initial public offering, with stocks soaring.
Dartmouth’s grass is greener with fund
Dartmouth College closes alumni-driven $1.5m investment fund.
Chiasma recovers to secure $33.8m
Following a cancelled deal with pharmaceutical company Roche, the Ofer-backed pharmaceutical company has raised the first tranche of a planned $56.3m series E round.
LBS to become “Davos of Finance”
London Business School receives £10m ($15m) from US-based hedge fund AQR Capital to set up investment institute.
Aveva snaps up 8over8 for £27m
Power plant construction firm Aveva acquires Ulster spin-out 8over8 in deal worth £27m ($41m).
Spin-out Cambridge Semiconductor acquired by Silicon Valley-based electronic components firm Power Integrations.
Philadelphia spin-out sparks IPO
Spark Therapeutics, a drug developer spin-out of Philadelphia University, files for IPO.
Fruit from IP’s US expansion hovers into view
UK-based commercialisation firm IP Group invests $1m into Exyn Technologies – the first spin-out to come out of its relationship with Pennsylvania University.
